About ORLYNVAH™ ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI. ORLYNVAH™ possesses potent activity against species of Enterobacterales including those that encode extended spectrum beta-lactamase (ESBL) or AmpC-type beta-lactamases that confer resistance to third generation cephalosporins. This Poster will be available on the Company's website on the "Publications: Posters & Presentations" page under the "Our Science" tab. About Iterum Therapeutics plc Iterum Therapeutics plc is focus ...